Restoring Biological Harmony for Patients with Debilitating Disease
We are harnessing the power of microRNA science to develop therapies that normalize biological pathways and counterbalance disease.
Learn More
DEVELOPMENT PROGRAMS
Our pipeline is focused on serious diseases of high unmet need where the latest discoveries in microRNA biology are challenging traditional drug development paradigms and creating opportunities for novel therapeutic approaches.
Recent Press Releases
- miRagen Therapeutics to Present New Cobomarsen Clinical Trial Data for Adult T-Cell Leukemia/Lymphoma at Two Upcoming Conferences
- miRagen Announces Major Changes to Company’s Strategy
- miRagen to Present at the Evercore ISI HealthCONx Conference 2019
- miRagen Reports Third Quarter 2019 Results and Provides Corporate Update
- miRagen to Present at the DIA/FDA Oligonucleotide-Based Therapeutics Conference Today